Segment Information |
Segment Information The Company reports two operating segments, U.S. and International, based on geographic customer base. The results of these operating segments are regularly reviewed by the Company’s chief operating decision maker, the President and Chief Executive Officer. The Company’s segments derive revenues through the manufacture, marketing, selling and distribution of medical imaging products, focused primarily on cardiovascular diagnostic imaging. All goodwill has been allocated to the U.S. operating segment. The Company does not identify or allocate assets to its segments. Selected information regarding the Company’s segments are provided as follows: | | | | | | | | | | | | | | Year Ended December 31, | (in thousands) | 2019 | | 2018 | | 2017 | Revenue by product from external customers | | | | | | U.S. | | | | | | DEFINITY | $ | 211,777 |
| | $ | 178,440 |
| | $ | 153,581 |
| TechneLite | 72,534 |
| | 74,042 |
| | 90,489 |
| Other nuclear | 36,231 |
| | 48,935 |
| | 54,822 |
| Rebates and allowances | (16,553 | ) | | (12,837 | ) | | (8,890 | ) | Total U.S. Revenues | 303,989 |
| | 288,580 |
| | 290,002 |
| International | | | | | | DEFINITY | 5,731 |
| | 4,633 |
| | 3,687 |
| TechneLite | 14,058 |
| | 24,816 |
| | 14,155 |
| Other nuclear | 23,574 |
| | 25,349 |
| | 23,558 |
| Rebates and allowances | (15 | ) | | (4 | ) | | (24 | ) | Total International Revenues | 43,348 |
| | 54,794 |
| | 41,376 |
| Worldwide | | | | | | DEFINITY | 217,508 |
| | 183,073 |
| | 157,268 |
| TechneLite | 86,592 |
| | 98,858 |
| | 104,644 |
| Other nuclear | 59,805 |
| | 74,284 |
| | 78,380 |
| Rebates and allowances | (16,568 | ) | | (12,841 | ) | | (8,914 | ) | Total Revenues | $ | 347,337 |
| | $ | 343,374 |
| | $ | 331,378 |
|
| | | | | | | | | | | | | | Year Ended December 31, | (in thousands) | 2019 | | 2018 | | 2017 | Geographical revenues | | | | | | U.S. | $ | 303,989 |
| | $ | 288,580 |
| | $ | 290,002 |
| International | 43,348 |
| | 54,794 |
| | 41,376 |
| Total revenues | $ | 347,337 |
| | $ | 343,374 |
| | $ | 331,378 |
| | | | | | | Operating income | | | | | | U.S. | $ | 44,275 |
| | $ | 56,327 |
| | $ | 49,239 |
| International | 7,386 |
| | 8,161 |
| | 2,614 |
| Operating income | 51,661 |
| | 64,488 |
| | 51,853 |
| Interest expense | 13,617 |
| | 17,405 |
| | 18,410 |
| Loss on extinguishment of debt | 3,196 |
| | — |
| | 2,442 |
| Other expense (income) | 6,221 |
| | (2,465 | ) | | (8,638 | ) | Income before income taxes | $ | 28,627 |
| | $ | 49,548 |
| | $ | 39,639 |
| | | | | | | Depreciation and amortization | | | | | | U.S. | $ | 11,673 |
| | $ | 12,278 |
| | $ | 17,672 |
| International | 414 |
| | 491 |
| | 517 |
| Total depreciation and amortization | $ | 12,087 |
| | $ | 12,769 |
| | $ | 18,189 |
|
| | | | | | | | | | December 31, | (in thousands) | 2019 | | 2018 | Long-lived assets | | | | U.S. | $ | 115,560 |
| | $ | 106,755 |
| International | 937 |
| | 1,133 |
| Total long-lived assets | $ | 116,497 |
| | $ | 107,888 |
|
|